This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Compare total market funds to determine which has the lowest fees, balancing expense ratios with diversification and performance history.
28,601 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...
In a shifting housing market, a 58-year-old nurse with $600k saved is pursuing a disciplined plan to buy a home. The ...
AARP launches its largest Community Challenge round yet, awarding $8.3 million to fund 750 projects that upgrade hous...
Stocks slip as growth signals and policy expectations shift in early 2026. This report outlines practical tips surviv...
A new ETF from Alpha Architect is drawing attention for tax-driven gains. BOXX aims to cut taxes for high earners by ...
As mortgage rates and prices wobble, first-time buyers face a tougher path. Experts urge a disciplined plan and reali...
Grab's CEO recently sold 400,000 Class A shares for about $1.6 million. This insider move raises the question: should...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
As AI data centers surge, the choice between Constellation Energy and Vistra hinges on reliability, cost, and market ...